Polifeprosan 20

未知生产厂商

Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Polifeprosan 20 is under investigation in clinical trial NCT00003878 (Carmustine Implants in Treating Patients With Brain Metastases).

技术标识符

CAS 编号: 90409-78-2
UNII ID: S40C40DA21

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Anticancer sustained-released injection containing taxane
- CN 101336899 A
  申请人: JINAN SHUAIHUA MEDICINE SCIENC优先权: 2006
  CN
- CN 101336900 A
  申请人: JINAN SHUAIHUA MEDICINE SCIENC优先权: 2006
  CN
Anticancer sustained-release formulation loaded with platinum compound and synergist thereof
CN 101380296 A申请人: JINAN KANGQUAN PHARMACEUTICAL优先权: 2006
CN
Anticancer sustained-released formulation loaded with platinum compound and synergist thereof
CN 101336898 A申请人: JINAN SHUAIHUA MEDICINE SCIENC优先权: 2006
CN
Compound platinum medicine sustained-release agent
- CN 101380297 A
  申请人: JINAN SHUAIHUA PHARMACEUTICAL优先权: 2006
  CN
- CN 101380306 A
  申请人: JINAN SHUAIHUA PHARMACEUTICAL优先权: 2006
  CN
Anticancer slow release agent of anticancer antibiotics and its progression agent
CN 1923286 A申请人: JINAN KANGQUAN PHARMACEUTICAL优先权: 2006
CN
Drug slow release agent comprising anticancer antibiotics and booster thereof
CN 1923172 A申请人: JINAN KANGQUAN PHARMACEUTICAL优先权: 2006
CN
Compound anticancer sustained-release injection containing vascular inhibitor
CN 101352414 A申请人: JINAN KANGQUAN MEDICINE INDUST优先权: 2006
CN
Gemcitabine-containing anti-cancer medicine sustained-release injection
CN 101427994 B申请人: SHANDONG LANJIN PHARMACEUTICALS CO LTD优先权: 2006
CN
Anti-cancer drug slow release injection containing gemcitabine
CN 101637444 B申请人: SHANDONG LANJIN PHARMACEUTICALS CO LTD优先权: 2006
CN
Antimetabolites and potentiating agent thereof carried by anticancer sustained-release injection
CN 101297970 A申请人: SHANDONG LANJIN BIOLOG ENGINEE优先权: 2006
CN

药物

Polifeprosan 20

概览

专利

Anticancer sustained-released injection containing taxane

Compound platinum medicine sustained-release agent